Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Medtronic plc. Ordinary Shares Stock Price: Quote, Financials, Forecast & News (MDT)

Markets open

Medtronic plc. Ordinary Shares

MDT · NYSE

Overview Financials Earnings Holders Historical Data Analysis

$85.83-$0.410.48%

As of: Aug 5, 2:30 PM

Prev Close: $86.20
Market Cap: $109.87B
Open: —
Trailing P/E: —
Day Range: $86.83 - $85.42
52W Range: $106.33 - $73.31
Forward P/E: —
EPS: —
Volume: 661.79K
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Retirees: 3 High-Yielding Dividend Stocks to Buy for Long-Term Stability and Recurring Cash Flow

The Motley Fool · 1d ago

Medtronic (MDT) Laps the Stock Market: Here's Why

Zacks · 2d ago

ACWI, LMT, SO, MDT: Large Outflows Detected at ETF

BNK Invest · 2d ago

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks · 6d ago

This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run

The Motley Fool · Jul 29 Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends

Zacks · Jul 28 Pre-Market Most Active for Jul 28, 2026 : DFNS, MUU, TQQQ, FIRY, LVWR, SQQQ, TSLL, NOK, SKDD, MDT, GLW, TE

NASDAQ.com · Jul 28 Buy Texas Instruments as a Momentum Play After Solid Q2 2026 Earnings

Zacks · Jul 28

Symbol: MDT
Type: Stock
Sector: Health Care
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus
Country: North America
Exchange: NYSE

Medtronic plc , headquartered in Galway, Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

Analyst Consensus

Buy

27 analysts

$86

Current

—

Low

$96

Average

—

High

Average target implies +11.85% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Vertex Pharmaceuticals IncorporatedVRTX · NASDAQ-GS

$482.570.81%

Bristol-Myers Squibb CompanyBMY · NYSE$63.863.08%

Pfizer, Inc.PFE · NYSE$25.520.41%

Gilead Sciences, Inc.GILD · Nasdaq$131.612.70%

Beta

—

Avg Volume

5.00M